Get set for a new exciting conference experience coming this spring from Health 2.0 and HIMSS, focused on the collaboration between developers and healthcare providers on building emerging digital health technologies: Dev4Health.
Join hundreds of developers, innovative leaders, designers, chief technology officers, chief innovation officers, start-ups, and health tech enthusiasts for two days of strategic networking, idea generation, and innovative workshops – plus live demos some of the newest health tech start-ups.
Top Reasons to Attend Dev4Health:
Innovation Leaders: Hear cutting edge ideas to infuse your technology strategy with the latest insights and methodologies.
Developers: Benefit from immersive content and hands-on learning by sharing open-source code, applications, interfaces and other resources with like-minded developers.
Health Systems: Discover the latest health tech products to hit the market with live demos by some of the most innovative start-ups in healthcare.
All Attendees: Join in-depth panel sessions focusing on health tech trends, including open tools in the U.S. healthcare server; healthcare focused developer programs; artificial intelligence and machine learning; blockchain; and more!
What are you waiting for? If you’re looking to collaborate with developers on building new applications
or discover new tools to enhance the healthcare experience, then Dev4Health is the place to be this spring.
Opioid overdoses are the leading cause of death for Americans under 50 years old. In fact, the majority of drug overdose related deaths involve an opioid. According to the National Center for Health Statistics, deaths from prescription opioids—drugs like oxycodone, hydrocodone, and methadone—have more than quadrupled since 1999. The U.S. is currently experiencing an opioid epidemic, as more than 2 million Americans have become dependent on, or abused prescription pain pills and street drugs. Substance misuse is not only affecting the users but also their families, friends, and the healthcare system as a whole.
Although improvements have been made to the way opioids are prescribed through clinical practice guidelines, the epidemic has continued to grow. The CDC has made several efforts to combat substance misuse and overdose but there is much more to be done, and you can help. The Robert Wood Johnson Foundation (RWJF) is committed to supporting those affected by this issue and launched the RWJF Opioid Challenge live, at Health 2.0’s Wintertech conference in January 2018. This innovation challenge calls for tech-enabled solutions that help identify resources, facilities, and educational content for support, as well as platforms for connecting patients, caregivers and peers for peer community.
RWJF has teamed up with Catalyst @ Health 2.0 to identify and incentivize the development of tech-enabled solutions that should aim to support affected individuals (e.g. opioid users, caregivers, peers, family, etc.) and connect them to relevant resources. Every individual faces a different set of challenges, meaning that needs for recovery can be unique and varied.* The challenge is calling on innovators, developers, entrepreneurs and other bright minds to create tools to support those affected by opioid misuse.
Earlier this week Health 2.0 held a TECHquality meetup focused on diversity in the digital health industry. We hoped that this event would foster an honest and frank discussion about how we can create diverse workplaces and develop inclusive technology for the people we serve. After speakers, Jean-Luc Neptune, Co-Founder at Athletik Health and Nyala Khan, VP of People at Baby+Co, shared their thoughts, meetup attendees were encouraged to share their own experiences and comments in relation to the topic at hand. Following an engaging and insightful discussion, where people of different backgrounds and walks of life shared their individual viewpoints, the hard questions remained, what more can we do to ensure that our workplaces are not only diverse, but inclusive? How do we ensure that the companies we build with people, embed the diverse perspectives of those people from the very start?
Last week at Health 2.0’s Wintertech, held during “health care’s money week” JP Morgan in San Francisco, Cambia CEO Mark Ganz gave a remarkable talk–one you wouldn’t expect from the leader of a big health insurer. He called out pharma for price gouging, he asked what consumers would think about the conversations we are having, but mostly he asked people to think about why they were working in health care. And he did it with a deeply personal set of stories. Everyone there found it very moving and very important, so I wanted to share it with the THCB audience. It’s well worth your time to watch. — Matthew Holt
A spin-off of the popular 3 CEOs session from the Fall Conference, the 4 CEOs and Their VCs session is made up of four, back-to-back interviews between digital health CEOs and the VCs who believe in them. Hear exclusive insight into what’s happening in health tech investments with conversations between:
Venrock and Robin:Robin is a brand new digital assistant for doctors. Hear Venrock Partner Bryan Roberts and Robin CEO Punit Son discuss the opportunities Venrock sees in Robin.
415 and Lemonaid: Patient experience has gotten easier with Lemonaid’s accessible online platform. Lemonaid CEO Paul Johnson sits with investment firm 415 to talk about their business strategy.
Thrive Capital and Honor: An online service that connects in-home caregivers, seniors and their families, Honor sits down with its investor Thrive Capital to discuss the purpose of their investment.
Grandrounds and Venrock: Owen Tripp of Grandrounds and Bob Kocher of Venrock discuss their working partnership, and give insight into what those closed-door meetings look like.
From Seed to Series C, don’t miss the opportunity to join the session that is representing each unique stage of the investment cycle. Tickets are selling fast so register today!
Millions of Americans have adorned themselves with glimmering Fitbits, Jawbones, Nike Fuelbands, and Misfits, Basis, Withings, and Garmin bracelets over the years. The devices have become so mainstream even Grandma has one. Perhaps the fact that Grandma is now tracking her data means that the industry is ripe for a change.
Recently though we’ve seen the popularity of wearables wane considerably. This month Mike and Albert Lee, founders of myfitnesspal announced that they would be departing from Under Armour; and we learned that Adidas is dropping their wearables division entirely.
Why? Its a fairly easy question to answer. Under Armour spent 2017 falling from grace and it’s possible their waning interest in connected fitness is due both to financial constraints as well as a series of departures of senior-level talent including Robin Thurston (MapMyRun), and Mette Lykke (Endomondo). Looking at Adidas though, they are dropping their dedicated connected fitness division in favor of a more distributed and integrated approach.
With this shift upon us, what is next wave of innovation? Let’s look at two companies.
Habit, the bay-area based company, collects genetics, vitals and metabolism of their customers; and uses their data and machine learning algorithms to deliver personal nutrition plans that align with the user’s health goals. Parsley Health is redefining primary care medicine by committing their doctors to whole-body health than to quick fixes and bonuses.
Health 2.0 just wrapped up its inaugural Technology For Precision Health Summit. A collective group of investors, entrepreneurs, and precision health workers gathered for a day of sharing, charged discussion, and live technology demos; all with the goal of pushing hard to advance an industry that is often a matter of live or death.
Some major themes emerged throughout the day including:
>Bridging Data Silos
>Identifying Federal Policies that are either stifling or catalyzing innovation
WinterTech is almost one month away, and we’re extremely excited about the final agenda. The 2018 edition of WinterTech will be not only be focusing on the new investment treads in digital health, but will take a in-depth look into the revolution in choice within the consumer landscape and the rapid development of digital therapeutics.
Our jam-packed 1-day conference includes:
Keynote presentation on how to create seamless health care experiences to meet the needs of consumers by Mark Ganz, CEO of Cambia Health.
Panel discussion on the opportunities, roadblocks, and regulations within the field of digital therapeutics by Bakul Patel, Associate Director for Digital Health at the FDA.
Imagine if you will, a future in which a cancer diagnosis will be treated with a lifestyle change, like a chronic condition. Survivable. Manageable. Like Diabetes. Sure, to receive a cancer diagnosis today does not mean what it meant twenty years ago, but we are also unlikely to reach a point of ever acting casual about the term or the treatment plan.
In the meantime though, the increasing prevalence of personal data collection is driving new approaches in care plans that have a real shot at improving quality of life. The narrative of one’s life can be seen in the data – everything from where you live, what you eat, how you workout, even what you search for on the internet. The sources of such personal data come from places like clinical trials, biosensors, and wearables and is being stored in your Electronic Medical Record.
The sticking point though is the advancement of technological tools to view, aggregate, extract, and analyze relevant data to derive a meaningful plan of attack (er, treatment plan). One interoperable tool that plugs right into the EMR is Cota Healthcare. Pair this with omics data and genome sequencing technology, like 2bPrecise, and physicians are gaining insight into what makes you, you. And thus are better able to customize a bespoke cancer treatment plan, designed for you and only you.
Health 2.0 caught up with some of our favorite investors who have a strong pulse on what’s happening in digital health care both past and present. We talked about company evaluation, unmet needs in health care, and their biggest surprises yet.
“Pretty much all of my investments are in first time CEOs, which is not particularly what the venture capital playbook tells you to go do. But I find those people to be very hungry and largely underappreciated by the rest of the world. They’re also very willing to bash their head against a brick wall with me for a while, in order to try to succeed at something that is hard to do.” – Bryan Roberts, Venrock on what he looks for in an investment.
“There are so “many tech people who want to work their way into health care venture capital. When I started in health care venture in 1998 you couldn’t give it away. I wonder how long it will be before the cycle ends?”
– Lisa Suennen, GE Ventures on what surprises her about the industry right now.
Catch up with Lisa Suennen, Bryan Roberts, and others at Health 2.0’s WinterTech event on January 10, 2018 in San Francisco where you’ll hear more on investment trends, IPO, and the rise in consumer choices. Register today for WinterTech before the early price ends.